Aigen Investment Management’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-9,662
Closed -$205K 932
2024
Q3
$205K Buy
+9,662
New +$174K 0.04% 581
2024
Q2
Sell
-26,258
Closed -$390K 956
2024
Q1
$390K Buy
26,258
+10,592
+68% +$145K 0.09% 350
2023
Q4
$143K Sell
15,666
-61,019
-80% -$421K 0.03% 708
2023
Q3
$427K Buy
+76,685
New +$537K 0.08% 411
2022
Q4
Sell
-15,235
Closed -$76K 707
2022
Q3
$76K Buy
+15,235
New +$88.9K 0.01% 555
2022
Q1
Sell
-18,195
Closed -$162K 930
2021
Q4
$162K Buy
+18,195
New +$228K 0.01% 960

Other funds holding OSCR

Aigen Investment Management's OSCR Position: Q4 2024 in Review

Aigen Investment Management sold out of Oscar Health (OSCR) in Q4 2024, closing a stake of 9,662 shares — an estimated $205K sold.

Aigen Investment Management first reported a position in OSCR in Q4 2021 and held it in 6 quarters. The position peaked at $427K in Q3 2023. 263 funds tracked by Wall St. Rank hold OSCR as of Q4 2024.

  • Aigen Investment Management reported no remaining Oscar Health position as of Q4 2024 after selling out during the quarter.
  • Aigen Investment Management sold 9,662 Oscar Health shares in Q4 2024, an estimated $205K.
  • Aigen Investment Management first reported a position in Oscar Health in Q4 2021 and held it in 6 quarters.
  • Aigen Investment Management's Oscar Health position peaked at $427K in Q3 2023.
  • 263 funds tracked by Wall St. Rank held Oscar Health as of Q4 2024.

Based on Aigen Investment Management's 13F filing for Q4 2024, filed 6 Feb 2025.